1	Nuclear	nuclear	_	_	_	_	_	_	_
2	factor	factor	_	_	_	_	_	_	_
3	kappa	kappa	_	_	_	_	_	_	_
4	B	B	_	_	_	_	_	_	_
5	activates	activate	_	_	_	_	_	_	_
6	proenkephalin	proenkephalin	_	_	_	_	_	_	_
7	transcription	transcription	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	lymphocytes	lymphocyte	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	Upon	upon	_	_	_	_	_	_	_
2	activation	activation	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	T	t	_	_	_	_	_	_	_
5	lymphocytes	lymphocyte	_	_	_	_	_	_	_
6	accumulate	accumulate	_	_	_	_	_	_	_
7	high	high	_	_	_	_	_	_	_
8	levels	level	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	neuropeptide	neuropeptide	_	_	_	_	_	_	_
12	enkephalin	enkephalin	_	_	_	_	_	_	_
13	which	which	_	_	_	_	_	_	_
14	correlate	correlate	_	_	_	_	_	_	_
15	with	with	_	_	_	_	_	_	_
16	high	high	_	_	_	_	_	_	_
17	levels	level	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	proenkephalin	proenkephalin	_	_	_	_	_	_	_
20	mRNA	mrna	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Here	here	_	_	_	_	_	_	_
2	we	we	_	_	_	_	_	_	_
3	investigated	investigate	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	transcriptional	transcriptional	_	_	_	_	_	_	_
6	basis	basis	_	_	_	_	_	_	_
7	for	for	_	_	_	_	_	_	_
8	these	these	_	_	_	_	_	_	_
9	changes	change	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	proenkephalin	proenkephalin	_	_	_	_	_	_	_
3	promoter	promoter	_	_	_	_	_	_	_
4	contains	contain	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	sequence	sequence	_	_	_	_	_	_	_
7	GGGGACGTCCCC	GGGGACGTCCCC	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	named	name	_	_	_	_	_	_	_
10	B2	b2	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	which	which	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	similar	similar	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	kappa	kappa	_	_	_	_	_	_	_
18	B	B	_	_	_	_	_	_	_
19	sequence	sequence	_	_	_	_	_	_	_
20	GGGGACTTTCC	GGGGACTTTCC	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	binding	bind	_	_	_	_	_	_	_
24	site	site	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	transcription	transcription	_	_	_	_	_	_	_
28	factor	factor	_	_	_	_	_	_	_
29	nuclear	nuclear	_	_	_	_	_	_	_
30	factor	factor	_	_	_	_	_	_	_
31	(	(	_	_	_	_	_	_	_
32	NF)-kappa	NF)-kappa	_	_	_	_	_	_	_
33	B.	B.	_	_	_	_	_	_	_
34	Activation	Activation	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	T	t	_	_	_	_	_	_	_
37	lymphocytes	lymphocyte	_	_	_	_	_	_	_
38	induces	induce	_	_	_	_	_	_	_
39	an	an	_	_	_	_	_	_	_
40	NF-kappa	NF-kappa	_	_	_	_	_	_	_
41	B-like	b-like	_	_	_	_	_	_	_
42	binding	binding	_	_	_	_	_	_	_
43	activity	activity	_	_	_	_	_	_	_
44	to	to	_	_	_	_	_	_	_
45	the	the	_	_	_	_	_	_	_
46	B2	b2	_	_	_	_	_	_	_
47	site	site	_	_	_	_	_	_	_
48	,	,	_	_	_	_	_	_	_
49	concomitant	concomitant	_	_	_	_	_	_	_
50	with	with	_	_	_	_	_	_	_
51	activation	activation	_	_	_	_	_	_	_
52	of	of	_	_	_	_	_	_	_
53	the	the	_	_	_	_	_	_	_
54	proenkephalin	proenkephalin	_	_	_	_	_	_	_
55	promoter	promoter	_	_	_	_	_	_	_
56	.	.	_	_	_	_	_	_	_

1	Mutations	mutation	_	_	_	_	_	_	_
2	at	at	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	B2	b2	_	_	_	_	_	_	_
5	site	site	_	_	_	_	_	_	_
6	abolish	abolish	_	_	_	_	_	_	_
7	this	this	_	_	_	_	_	_	_
8	transcriptional	transcriptional	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	purified	purify	_	_	_	_	_	_	_
3	homodimer	homodimer	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	two	two	_	_	_	_	_	_	_
6	p50s	p50	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	DNA-binding	dna-binding	_	_	_	_	_	_	_
11	subunit	subunit	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	NF-kappa	NF-kappa	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	binds	bind	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	B2	b2	_	_	_	_	_	_	_
18	site	site	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	proenkephalin	proenkephalin	_	_	_	_	_	_	_
21	relatively	relatively	_	_	_	_	_	_	_
22	better	well	_	_	_	_	_	_	_
23	than	than	_	_	_	_	_	_	_
24	does	do	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	heterotetramer	heterotetramer	_	_	_	_	_	_	_
27	(	(	_	_	_	_	_	_	_
28	two	two	_	_	_	_	_	_	_
29	p65s	p65	_	_	_	_	_	_	_
30	plus	plus	_	_	_	_	_	_	_
31	two	two	_	_	_	_	_	_	_
32	p50s	p50	_	_	_	_	_	_	_
33	)	)	_	_	_	_	_	_	_
34	form	form	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	the	the	_	_	_	_	_	_	_
37	factor	factor	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	it	it	_	_	_	_	_	_	_
4	appears	appear	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	T-cell-specific	t-cell-specific	_	_	_	_	_	_	_
8	activation	activation	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	proenkephalin	proenkephalin	_	_	_	_	_	_	_
12	promoter	promoter	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	mediated	mediate	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	NF-kappa	NF-kappa	_	_	_	_	_	_	_
17	B.	B.	_	_	_	_	_	_	_
18	However	however	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	as	as	_	_	_	_	_	_	_
21	NF-kappa	NF-kappa	_	_	_	_	_	_	_
22	B	B	_	_	_	_	_	_	_
23	is	be	_	_	_	_	_	_	_
24	ubiquitous	ubiquitous	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	transcriptional	transcriptional	_	_	_	_	_	_	_
28	activation	activation	_	_	_	_	_	_	_
29	through	through	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	B2	b2	_	_	_	_	_	_	_
32	site	site	_	_	_	_	_	_	_
33	is	be	_	_	_	_	_	_	_
34	T	t	_	_	_	_	_	_	_
35	cell	cell	_	_	_	_	_	_	_
36	specific	specific	_	_	_	_	_	_	_
37	,	,	_	_	_	_	_	_	_
38	yet	yet	_	_	_	_	_	_	_
39	another	another	_	_	_	_	_	_	_
40	T-cell-specific	t-cell-specific	_	_	_	_	_	_	_
41	factor	factor	_	_	_	_	_	_	_
42	which	which	_	_	_	_	_	_	_
43	synergizes	synergize	_	_	_	_	_	_	_
44	with	with	_	_	_	_	_	_	_
45	NF-kappa	NF-kappa	_	_	_	_	_	_	_
46	B	B	_	_	_	_	_	_	_
47	should	should	_	_	_	_	_	_	_
48	be	be	_	_	_	_	_	_	_
49	considered	consider	_	_	_	_	_	_	_
50	.	.	_	_	_	_	_	_	_

